Cathay Biotech (SHSE:688065) Total Equity : ¥14,864 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Total Equity?

Cathay Biotech's total equity for the quarter that ended in Mar. 2024 was ¥14,864 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cathay Biotech Total Equity Historical Data

The historical data trend for Cathay Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Total Equity Chart

Cathay Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

4,641.86

11,484.41

14,674.38

15,038.21

14,773.11

Cathay Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial															15,114.26	15,194.47	15,266.74	14,773.11	14,863.90

Cathay Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cathay Biotech's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	18833.373	-	4060.263
	=	14,773

Cathay Biotech's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	18617.744	-	3753.844
	=	14,864

Cathay Biotech Total Equity Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cathay Biotech (SHSE:688065) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Total Equity

Traded in Other Exchanges

N/A

Address

1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.cathaybiotech.com

Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines